Holdings
Bvf Inc
As of Sep 30, 2026, Bvf Inc reported 41 positions worth US$2.43B. Largest: Revolution Medicines, Inc., Kymera Therapeutics, Inc. and Xencor, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Revolution Medicines, Inc. | 2.46M | US$505M | −505K | Sep 30, 2026 |
| Kymera Therapeutics, Inc. | 3.87M | US$433M | no change | Sep 30, 2026 |
| Xencor, Inc. | 6.23M | US$155M | −907K | Sep 30, 2026 |
| Nektar Therapeutics | 2.13M | US$129M | −257K | Sep 30, 2026 |
| Stoke Therapeutics, Inc. | 3.61M | US$93.8M | +1.06M | Sep 30, 2026 |
| Tyra Biosciences, Inc. | 4.22M | US$92.2M | +2.74M | Sep 30, 2026 |
| Zymeworks Inc. | 3.46M | US$91.8M | −185K | Sep 30, 2026 |
| Cullinan Therapeutics, Inc. | 5.75M | US$88.3M | no change | Sep 30, 2026 |
| Structure Therapeutics, Inc. | 2.69M | US$84.2M | new | Sep 30, 2026 |
| Palvella Therapeutics, Inc. | 607K | US$83.7M | −65,640 | Sep 30, 2026 |